Comparison of survival outcomes of neoadjuvant therapy and direct surgery in IB2/IIA2 cervical adenocarcinoma: a retrospective study

被引:0
|
作者
Peilin Ouyang
Jingting Cai
Lin Gui
Shan Liu
Na-Yi Yuan Wu
Jing Wang
机构
[1] Central South University,Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine
[2] Central South University,Xiangya School of Medicine
来源
关键词
Cervical adenocarcinoma; NACT; NACRT; Radical surgery; Survival;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1247 / 1255
页数:8
相关论文
共 50 条
  • [41] Analysis of clinical and angiogenesis factors with cervical cancer stage IB2 And IIA2 neo-adjuvant chemotherapy responses
    Muhammad, Syamel
    Susanti, Restu
    Hidayat, Yudi Mulyana
    Muthmainnah, Diniy Miftahul
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A82 - A82
  • [42] A Prospective Randomized Controlled Study on Multiple Neoadjuvant Treatments for Patients With Stage IB2 to IIA Cervical Cancer
    Wen, Hao
    Wu, Xiaohua
    Li, Ziting
    Wang, Huaying
    Zang, Rongyu
    Sun, Min
    Huang, Xiao
    Zhang, Zhiyi
    Cai, Shumo
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (02) : 296 - 302
  • [43] PHASE I DOSE ESCALATION STUDY OF WEEKLY PACLITAXEL AND CISPLATIN FOLLOWED BY RADICAL HYSTERECTOMY IN STAGES IB2 AND IIA2 CERVICAL CANCER
    Huang, H. J.
    Chou, H. H.
    Lin, H.
    Yang, L. Y.
    Hsueh, S.
    Liu, F. Y.
    Liou, Y. L.
    Liou, J. D.
    Chen, M. Y.
    Chao, A.
    Chang, T. C.
    Lai, C. H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 1173 - 1173
  • [44] Comparison of Neoadjuvant Chemotherapy Followed by Radical Surgery with Chemoradiation in Stage IB2 to IIB of Cervical Cancer
    Arab, Maliheh
    Hadi, Fatemeh
    Raoufi, Masoomeh
    Anbiaee, Robab
    Teymoordash, Somayyeh Noei
    Hosseini, Maryam Sadat
    Farzaneh, Farah
    Talayeh, Maryam
    Ganjouee, Tahereh Ashraf
    Azghandi, Samira
    Moridi, Atefeh
    Rooy, Rezvaneh Sadat Beheshti
    Amiri, Fatemeh
    INTERNATIONAL JOURNAL OF CANCER MANAGEMENT, 2024, 17 (01)
  • [45] Clinico-pathological factors predicting parametrial invasion in IB2, IIA1, IIA2 (FIGO2009) cervical cancer
    Hsu, H. C.
    Cheng, W. F.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 199 - 199
  • [46] The Effect of Neoadjuvant Chemotherapy Combined With Brachytherapy Before Radical Hysterectomy on Stage IB2 and IIA Cervical Cancer: A Retrospective Analysis
    Dang, Yun
    Liu, Qing
    Long, Lixia
    Luan, Hua
    Shi, Qingfang
    Tuo, Xunyuan
    Tuo, Shumei
    Li, Yilin
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [47] Radical hysterectomy with or without para-aortic lymphadenectomy for patients with stage IB2, IIA2, and IIB cervical cancer: outcomes for a series of 308 patients
    Tsuruga, Tetsushi
    Fujimoto, Asaha
    Kawana, Kei
    Mori, Mayuyo
    Hasumi, Yoko
    Kino, Nao
    Tomio, Kensuke
    Miura, Shiho
    Tanikawa, Michihiro
    Sone, Kenbun
    Miyamoto, Yuichiro
    Ikeda, Yuji
    Kojima, Satoko
    Adachi, Katsuyuki
    Nagasaka, Kazunori
    Matsumoto, Yoko
    Arimoto, Takahide
    Oda, Katsutoshi
    Nakagawa, Shunsuke
    Horie, Koji
    Yasugi, Toshiharu
    Yokota, Harushige
    Osuga, Yutaka
    Fujii, Tomoyuki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2016, 21 (02) : 359 - 366
  • [48] CLINICAL APPLICATION VALUE OF CERVICAL CANCER RADICAL SURGERY PLUS VENTRAL PARA-AORTIC LYMPH NODE DISSECTION IN THE IB2 AND IIA2 CERVICAL CANCER TREATMENT
    Deng, Yun
    Xiao, Chuli
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 80 (01) : 64 - 64
  • [49] Effectiveness comparisons of various therapies for FIGO stage IB2/IIA2 cervical cancer: a Bayesian network meta-analysis
    Cheng, Jing
    Liu, Beibei
    Wang, Biao
    Long, Xicui
    Li, Zhihong
    Chen, Ruili
    Wu, Ruiting
    Xu, Lin
    BMC CANCER, 2021, 21 (01)
  • [50] CLINICAL EFFICACY ANALYSIS OF PREOPERATIVE NEOADJUVANT CHEMOTHERAPY WITH HIGH DOSE DENSE PACLITAXEL PLUS CISPLATIN IN STAGES IB2, IIA2, IIB CERVICAL CANCER IN IRAN
    Hashemi, F.
    Mousavi, A. S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1951 - 1951